Feldman, Golinski, Reedy + Ben-Zvi PLLC • 1700 Broadway, 28th Floor • New York, New York 10019 • Tel: 212.230.1300
Jonathan E. Rebell

As Of Counsel at Feldman, Golinski, Reedy + Ben-Zvi (“FGRB”), Jonathan E. Rebell is helping cutting edge companies with legal and business issues related to complex technology, content, digital media, and other intellectual property transactions. His practice is focused on the media and entertainment industry, with expertise in Advertising Technology, Marketing, Software as a Service (SaaS), Platform as a Service (PaaS), Content Distribution, Content Licensing, Software Licensing, Privacy, and Data Management. Jon also has extensive experience with all aspects of video OTT Platforms including AVOD, SVOD and FVOD models, as well as Augmented Reality (AR), Virtual Reality (VR) and Artificial Intelligence.

For over 13 years, Jon has built his legal career as in-house counsel for some of the top digital media and marketing companies in the world such as NBCUniversal, Viacom (including Nickelodeon) and Experian Marketing Services.  He has been on the front lines of helping his clients learn and navigate optimal uses of new technologies and incorporate compliance with new laws, regulations and legal trends in smart, business driven, practical ways.

Jon completed his undergraduate education at the University of Pennsylvania and graduated with honors from George Washington University Law School.  Jon is currently an Executive Committee member of the Leadership Council for Broadway Cares/Equity Fights AIDS. He previously served on the National Leadership Council for the Gay Lesbian Straight Education Network (GLSEN).

New York (2004)

George Washington University Law School, J.D., with Honors, 2003
Book Review Editor, The George Washington International Law Review.
Pro Bono Honor Recipient.

University of Pennsylvania, B.A., 1997
Outstanding Achievement Award for volunteer work.

Jon is currently an Executive Committee member of the Leadership Council for the Broadway Cares/Equity Fights AIDS.